439 related articles for article (PubMed ID: 22427315)
21. [Nephrogenic diabetes insipidus].
Evrard A; Lefebvre J; Vantyghem M
Ann Endocrinol (Paris); 1999 Dec; 60(6):457-64. PubMed ID: 10617799
[TBL] [Abstract][Full Text] [Related]
22. Nephrogenic diabetes insipidus.
Morello JP; Bichet DG
Annu Rev Physiol; 2001; 63():607-30. PubMed ID: 11181969
[TBL] [Abstract][Full Text] [Related]
23. Nephrogenic diabetes insipidus.
Bichet DG
Am J Med; 1998 Nov; 105(5):431-42. PubMed ID: 9831428
[TBL] [Abstract][Full Text] [Related]
24. [Congenital nephrogenic diabetes insipidus].
Morin D; Delenne AL; Kervran A
Arch Pediatr; 2005 Jan; 12(1):59-66. PubMed ID: 15653057
[TBL] [Abstract][Full Text] [Related]
25. A mini-review of pharmacological strategies used to ameliorate polyuria associated with X-linked nephrogenic diabetes insipidus.
Mortensen LA; Bistrup C; Jensen BL; Hinrichs GR
Am J Physiol Renal Physiol; 2020 Nov; 319(5):F746-F753. PubMed ID: 32924547
[TBL] [Abstract][Full Text] [Related]
26. Mutations in the vasopressin V2 receptor and aquaporin-2 genes in 12 families with congenital nephrogenic diabetes insipidus.
Vargas-Poussou R; Forestier L; Dautzenberg MD; Niaudet P; Déchaux M; Antignac C
J Am Soc Nephrol; 1997 Dec; 8(12):1855-62. PubMed ID: 9402087
[TBL] [Abstract][Full Text] [Related]
27. A novel mutation affecting the arginine-137 residue of AVPR2 in dizygous twins leads to nephrogenic diabetes insipidus and attenuated urine exosome aquaporin-2.
Hinrichs GR; Hansen LH; Nielsen MR; Fagerberg C; Dieperink H; Rittig S; Jensen BL
Physiol Rep; 2016 Apr; 4(8):. PubMed ID: 27117808
[TBL] [Abstract][Full Text] [Related]
28. Vasopressin-aquaporin-2 pathway: recent advances in understanding water balance disorders.
Ranieri M; Di Mise A; Tamma G; Valenti G
F1000Res; 2019; 8():. PubMed ID: 30800291
[TBL] [Abstract][Full Text] [Related]
29. [Pathological aspects of water transport in the collecting ducts].
Bichet DG
Nephrologie; 1996; 17(7):417-22. PubMed ID: 9019668
[TBL] [Abstract][Full Text] [Related]
30. GENETICS IN ENDOCRINOLOGY Pathophysiology, diagnosis and treatment of familial nephrogenic diabetes insipidus.
Bichet DG
Eur J Endocrinol; 2020 Aug; 183(2):R29-R40. PubMed ID: 32580146
[TBL] [Abstract][Full Text] [Related]
31. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
Savelkoul PJ; De Mattia F; Li Y; Kamsteeg EJ; Konings IB; van der Sluijs P; Deen PM
Hum Mutat; 2009 Oct; 30(10):E891-903. PubMed ID: 19585583
[TBL] [Abstract][Full Text] [Related]
32. Genetic basis of nephrogenic diabetes insipidus.
Hureaux M; Vargas-Poussou R
Mol Cell Endocrinol; 2023 Jan; 560():111825. PubMed ID: 36460218
[TBL] [Abstract][Full Text] [Related]
33. Molecular and cellular defects in nephrogenic diabetes insipidus.
Knoers NV; Deen PM
Pediatr Nephrol; 2001 Dec; 16(12):1146-52. PubMed ID: 11793119
[TBL] [Abstract][Full Text] [Related]
34. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.
de Mattia F; Savelkoul PJ; Kamsteeg EJ; Konings IB; van der Sluijs P; Mallmann R; Oksche A; Deen PM
J Am Soc Nephrol; 2005 Oct; 16(10):2872-80. PubMed ID: 16120822
[TBL] [Abstract][Full Text] [Related]
35. Aquaporin-2 water channel mutations causing nephrogenic diabetes insipidus.
van Os CH; Deen PM
Proc Assoc Am Physicians; 1998; 110(5):395-400. PubMed ID: 9756089
[TBL] [Abstract][Full Text] [Related]
36. Novel mutations associated with nephrogenic diabetes insipidus. A clinical-genetic study.
García Castaño A; Pérez de Nanclares G; Madariaga L; Aguirre M; Chocron S; Madrid A; Lafita Tejedor FJ; Gil Campos M; Sánchez Del Pozo J; Ruiz Cano R; Espino M; Gomez Vida JM; Santos F; García Nieto VM; Loza R; Rodríguez LM; Hidalgo Barquero E; Printza N; Camacho JA; Castaño L; Ariceta G;
Eur J Pediatr; 2015 Oct; 174(10):1373-85. PubMed ID: 25902753
[TBL] [Abstract][Full Text] [Related]
37. Fluconazole Increases Osmotic Water Transport in Renal Collecting Duct through Effects on Aquaporin-2 Trafficking.
Vukićević T; Hinze C; Baltzer S; Himmerkus N; Quintanova C; Zühlke K; Compton F; Ahlborn R; Dema A; Eichhorst J; Wiesner B; Bleich M; Schmidt-Ott KM; Klussmann E
J Am Soc Nephrol; 2019 May; 30(5):795-810. PubMed ID: 30988011
[TBL] [Abstract][Full Text] [Related]
38. Pathogenesis and treatment of autosomal-dominant nephrogenic diabetes insipidus caused by an aquaporin 2 mutation.
Sohara E; Rai T; Yang SS; Uchida K; Nitta K; Horita S; Ohno M; Harada A; Sasaki S; Uchida S
Proc Natl Acad Sci U S A; 2006 Sep; 103(38):14217-22. PubMed ID: 16968783
[TBL] [Abstract][Full Text] [Related]
39. Nephrogenic diabetes insipidus in mice caused by deleting COOH-terminal tail of aquaporin-2.
Shi PP; Cao XR; Qu J; Volk KA; Kirby P; Williamson RA; Stokes JB; Yang B
Am J Physiol Renal Physiol; 2007 May; 292(5):F1334-44. PubMed ID: 17229678
[TBL] [Abstract][Full Text] [Related]
40. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
Russo LM; McKee M; Brown D
Am J Physiol Renal Physiol; 2006 Jul; 291(1):F246-53. PubMed ID: 16449354
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]